Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
about
Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy.A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping.Construction of a tri-chromatic reporter cell line for the rapid and simple screening of splice-switching oligonucleotides targeting DMD exon 51 using high content screening.Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
P2860
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Quantitative Antisense Screeni ...... n Duchenne Muscular Dystrophy.
@en
Quantitative Antisense Screeni ...... n Duchenne Muscular Dystrophy.
@nl
type
label
Quantitative Antisense Screeni ...... n Duchenne Muscular Dystrophy.
@en
Quantitative Antisense Screeni ...... n Duchenne Muscular Dystrophy.
@nl
prefLabel
Quantitative Antisense Screeni ...... n Duchenne Muscular Dystrophy.
@en
Quantitative Antisense Screeni ...... n Duchenne Muscular Dystrophy.
@nl
P2093
P2860
P50
P1433
P1476
Quantitative Antisense Screeni ...... in Duchenne Muscular Dystrophy
@en
P2093
Aleksander Touznik
Bailey Miskew Nichols
Joshua Lee
Kamel Mamchaoui
Kenji Rowel Q Lim
Maria Candida Vila
Rika Maruyama
Shin'ichi Takeda
P2860
P304
P356
10.1016/J.YMTHE.2017.07.014
P577
2017-07-28T00:00:00Z